Byhealth Beheer

Beheer criteriumcontroles 3/4

De CEO Byhealth is Zhicheng Lin, benoemd in Sep2014, heeft een ambtstermijn van 10.17 jaar. bezit rechtstreeks 0.021% van de aandelen van het bedrijf, ter waarde CN¥ 4.51M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 10.2 jaar en 5.4 jaar.

Belangrijke informatie

Zhicheng Lin

Algemeen directeur

CN¥7.0m

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	10.2yrs
Eigendom CEO	0.02%
Management gemiddelde ambtstermijn	10.2yrs
Gemiddelde ambtstermijn bestuur	5.4yrs

Recente managementupdates

Recent updates

CEO

Zhicheng Lin (56 yo)

10.2yrs

Tenure

CN¥7,000,300

Compensatie

Mr. Zhicheng Lin has been Chief Executive Officer at Byhealth Co.,Ltd since September 26, 2014 and served as its Vice President and Secretary since June 2012 and since July 2012 respectively. Mr. Lin was D...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Zhicheng Lin	CEO & Non-Independent Director	10.2yrs	CN¥7.00m	0.021% CN¥ 4.5m
Jinyin Tang	Secretary to the Board of Directors	6.6yrs	CN¥1.04m	geen gegevens
Hong Chen	Deputy General Manager	16.2yrs	CN¥5.00m	1.05% CN¥ 229.2m
Liangping Cai	Deputy General Manager	10.2yrs	CN¥5.00m	0.032% CN¥ 6.9m

10.2yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 300146 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 10.2 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Zhicheng Lin	CEO & Non-Independent Director	10.2yrs	CN¥7.00m	0.021% CN¥ 4.5m
Shuisheng Liang	Non-Independent Vice Chairman	16.2yrs	CN¥5.00m	1.02% CN¥ 222.3m
Yunchao Liang	Non-Independent Chairman of the Board	16.2yrs	CN¥604.40k	42.17% CN¥ 9.2b
Yu Ming Hu	Independent Director	1.3yrs	CN¥42.60k	geen gegevens
Hui Tang	Non-Independent Director	16.2yrs	CN¥8.26m	0.43% CN¥ 92.8m
Heng Liu	Independent Director	1.3yrs	CN¥42.60k	geen gegevens
Zhuoyi Wu	Chairman of the Supervisory Board	1.3yrs	CN¥1.80m	geen gegevens
Huizhen Shi	Member of Supervisory Board	6.7yrs	geen gegevens	geen gegevens
Chuanyuan Deng	Independent Director	4.2yrs	CN¥120.00k	geen gegevens
Le Li	Supervisor	2.8yrs	geen gegevens	geen gegevens

5.4yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 300146 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.4 jaar).

Byhealth Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Byhealth Co., Ltd, Annual General Meeting, Apr 11, 2024

High number of new directors

Byhealth Co. Ltd. Approves Executive Appointments

By-health Co., Ltd., Annual General Meeting, Mar 26, 2021

By-health Co., Ltd. Announces Management Appointment

Recent updates

Third quarter 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.21 profit in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

Byhealth Co., Ltd to Report Q3, 2024 Results on Oct 26, 2024

Investor sentiment improves as stock rises 17%

New minor risk - Earnings quality

Second quarter 2024 earnings released: EPS: CN¥0.095 (vs CN¥0.30 in 2Q 2023)

Byhealth Co., Ltd to Report First Half, 2024 Results on Aug 06, 2024

First quarter 2024 earnings released: EPS: CN¥0.43 (vs CN¥0.61 in 1Q 2023)

Dividend increased to CN¥0.90

Byhealth Co., Ltd Approves Cash Dividend for the Year 2023

Byhealth Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024

Byhealth Co., Ltd Announces Profit Distribution Proposal for 2023

Byhealth Co., Ltd, Annual General Meeting, Apr 11, 2024

Full year 2023 earnings released: EPS: CN¥1.03 (vs CN¥0.82 in FY 2022)

Now 21% overvalued

Byhealth Co., Ltd to Report Fiscal Year 2023 Results on Mar 19, 2024

Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.25 in 3Q 2022)

Provexis plc Announces Byhealth Co., Ltd Regulatory Filing with Chinese SAMR

High number of new directors

Byhealth Co. Ltd. Approves Executive Appointments

Second quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.23 in 2Q 2022)

Byhealth Co., Ltd to Report First Half, 2023 Results on Aug 05, 2023

Full year 2022 earnings released: EPS: CN¥0.82 (vs CN¥1.06 in FY 2021)

Third quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.17 in 3Q 2021)

Second quarter 2022 earnings released

First quarter 2022 earnings released: EPS: CN¥0.39 (vs CN¥0.52 in 1Q 2021)

By-Health Co., Ltd. Implements Cash Dividend for 2021, Payable on 13 April 2022

By-Health Co., Ltd. Approves Cash Dividend for 2021

By-health Co., Ltd. Proposes Cash Dividend for 2021

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.32 in 3Q 2020)

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥0.52 (vs CN¥0.34 in 1Q 2020)

Investor sentiment improved over the past week

By-health Co., Ltd., Annual General Meeting, Mar 26, 2021

New 90-day high: CN¥28.08

Full year 2020 earnings released: EPS CN¥0.96 (vs CN¥0.24 loss in FY 2019)

Revenue misses expectations

New 90-day low: CN¥22.89

By-health Co., Ltd. to Report Fiscal Year 2020 Results on Mar 06, 2021

New 90-day high: CN¥25.87

Third quarter earnings released

By-health Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020

By-health Co., Ltd. Announces Management Appointment

New 90-day high - CN¥23.69

By-health Co., Ltd. to Report First Half, 2020 Results on Jul 30, 2020

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd